| 1581 |
National Cancer Institute |
Html |
en |
Thyroid Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of thyroid cancer. |
| thyroid hormone | 0.462109 |
| thyroid cells | 0.459144 |
| thyroid hormone levels | 0.441028 |
| body | 0.475956 |
| thyroid nodules | 0.440882 |
| thyroid hormone replacement | 0.418097 |
| type | 0.402327 |
| PDQ cancer information | 0.417269 |
| clinical trial search | 0.44196 |
| clinical trials | 0.712208 |
| thyroid cancer spreads | 0.460066 |
| radioactive iodine therapy | 0.447344 |
| cancer information summary | 0.398763 |
| clinical trial | 0.54371 |
| thyroid disease | 0.440863 |
| patients | 0.405549 |
| fine-needle aspiration biopsy | 0.401121 |
| sentinel lymph node | 0.409752 |
| thyroid tumor | 0.430395 |
| lymph nodes | 0.45279 |
| thyroid cancer cells | 0.479847 |
| thyroid cancer treatment | 0.491155 |
| radiation therapy | 0.478836 |
| medullary thyroid cancer | 0.563411 |
| tyrosine kinase inhibitor | 0.42467 |
|
| thyroid scan | 0.39797 |
| treatment | 0.554504 |
| childhood thyroid cancer | 0.480138 |
| thyroid nodule | 0.461177 |
| follicular thyroid cells | 0.442093 |
| metastatic thyroid cancer | 0.461409 |
| healthy thyroid | 0.426685 |
| undifferentiated thyroid cancer | 0.481926 |
| thyroid cancer | 0.866042 |
| cancer cells | 0.55043 |
| thyroid tissue | 0.43819 |
| familial medullary thyroid | 0.436692 |
| anaplastic thyroid cancer | 0.503212 |
| National Cancer Institute | 0.411413 |
| Thyroid hormones | 0.426342 |
| external radiation therapy | 0.459156 |
| papillary thyroid cancers | 0.4232 |
| differentiated thyroid cancer | 0.481235 |
| thyroid uses iodine | 0.446079 |
| cancer clinical trials | 0.453504 |
| stage | 0.433394 |
| tumor | 0.440267 |
| cancer | 0.979846 |
| information | 0.45122 |
|
CLICK HERE |
| 1611 |
National Cancer Institute |
Html |
en |
Late Effects of Treatment for Childhood Cancer (PDQ®)–Health Professional Version |
Serious, disabling, and life-threatening chronic health conditions adversely affect the health of aging childhood cancer survivors. Learn about the cardiovascular, cognitive, psychosocial, digestive, endocrine, immune, musculoskeletal, reproductive, and urinary late effects and subsequent neoplasms that contribute to a high burden of morbidity in childhood cancer survivors. |
| adult cancer survivors | 0.344142 |
| childhood leukemia survivors | 0.307057 |
| Childhood Cancer Guideline | 0.302298 |
| childhood cancer therapy | 0.296791 |
| long-term cancer survivors | 0.295333 |
| childhood cancer survivors | 0.499567 |
| Engl J Med | 0.269755 |
| Br J Cancer | 0.261959 |
| Cancer Survivor cohort | 0.269169 |
| Int J Cancer | 0.266011 |
| Ann Intern Med | 0.263377 |
| 5-year survivors | 0.295172 |
| cancer survivors research | 0.286942 |
| Radiat Oncol Biol | 0.277048 |
| breast cancer surveillance | 0.269328 |
| adult survivors | 0.315122 |
| Hudson MM | 0.309712 |
| young adult cancer | 0.340977 |
| British Childhood Cancer | 0.326521 |
| Natl Cancer Inst | 0.402086 |
| survivor study cohort | 0.273371 |
| Clin Cancer Res | 0.263669 |
| Irradiated Childhood Cancer | 0.298512 |
| childhood cancer | 0.912384 |
| cancer survivor study | 0.693286 |
|
| et al. | 0.431618 |
| late effects | 0.3275 |
| long-term survivors | 0.333244 |
| cohort study | 0.263432 |
| Cancer Epidemiol Biomarkers | 0.265429 |
| pediatric cancer survivors | 0.286679 |
| PUBMED Abstract | 0.35078 |
| Pediatr Blood Cancer | 0.447984 |
| radiation-induced breast cancer | 0.26406 |
| breast cancer risk | 0.280733 |
| Abstract | 0.467444 |
| Clin Oncol | 0.515912 |
| breast cancer | 0.391476 |
| Oncol Biol Phys | 0.278259 |
| childhood cancer survivor | 0.771953 |
| Cancer Guideline Harmonization | 0.260525 |
| young cancer survivors | 0.275759 |
| childhood cancer registry | 0.291062 |
| long-term follow-up guidelines | 0.273165 |
| Cancer J Clin | 0.270171 |
| report | 0.265432 |
| childhood cancer treatment | 0.287484 |
| oncology group | 0.32484 |
| long-term childhood cancer | 0.311378 |
|
CLICK HERE |
| 1704 |
National Cancer Institute |
Html |
en |
Psychological Stress and Cancer |
A fact sheet that describes the effects of stress on the body, the results of research on the relationship between stress and cancer, and information about coping with stress. |
| Sood AK | 0.622496 |
| cancer treatment | 0.603243 |
| primary breast cancer | 0.597411 |
| Antoni MH | 0.570507 |
| human cancer cells | 0.605494 |
| family member | 0.588007 |
| psychological distress | 0.593032 |
| fact sheet | 0.615559 |
| mammary fat pads | 0.570769 |
| emotional pressure | 0.583244 |
| Health care providers | 0.574848 |
| risky behaviors | 0.581446 |
| cancer metastasis | 0.572171 |
| social support | 0.574381 |
| triple-negative breast cancer | 0.658004 |
| various psychological factors | 0.615469 |
| Lutgendorf SK | 0.681275 |
| cancer patients | 0.656706 |
| cancer survival | 0.572148 |
| stress cause cancer | 0.708673 |
| blood sugar levels | 0.578812 |
| Clinical Oncology | 0.599718 |
| speed heart rate | 0.575901 |
| ovarian carcinoma patients | 0.577415 |
|
| higher rates | 0.57609 |
| specific psychological conditions | 0.622117 |
| Psychological Bulletin | 0.579687 |
| elevated tumor norepinephrine | 0.576809 |
| psychological stress | 0.974362 |
| beta blockers | 0.5732 |
| normal life activities | 0.583211 |
| physical health problems | 0.585785 |
| drinking alcohol | 0.576593 |
| cancer outcomes | 0.570999 |
| biobehavioral signaling pathways | 0.570101 |
| stress management techniques | 0.670628 |
| clinical health psychologist | 0.575253 |
| Cancer Research | 0.5705 |
| stress hormone norepinephrine | 0.675379 |
| poorer clinical outcomes | 0.584728 |
| stress hormones | 0.675405 |
| people | 0.602029 |
| certain stress hormones | 0.663467 |
| New patient-centered care | 0.571423 |
| close family member | 0.58133 |
| Related Resources | 0.579385 |
| et al | 0.674807 |
| Related Resources section | 0.573303 |
|
CLICK HERE |
| 1729 |
National Cancer Institute |
Html |
en |
Hyperthermia in Cancer Treatment |
A fact sheet that defines hyperthermia (treating tumors with heat) and its side effects. |
| cancer treatment | 0.403898 |
| peritoneal cavity temperature | 0.426528 |
| External applicators | 0.382217 |
| whole-body hyperthermia | 0.729094 |
| van der Zee | 0.371709 |
| Clinical Radiation Oncology. | 0.380706 |
| tumor location | 0.365525 |
| regional hyperthermia | 0.5725 |
| hyperthermic peritoneal perfusion | 0.490656 |
| metastatic cancer | 0.36336 |
| Gibbs FA Jr | 0.369277 |
| normal tissues | 0.422996 |
| cancer therapy | 0.407309 |
| hyperthermia treatment | 0.61506 |
| bladder cancer | 0.363102 |
| Deep tissue approaches | 0.386891 |
| clinical trials | 0.532546 |
| DeVita VT Jr. | 0.371357 |
| interstitial hyperthermia | 0.571391 |
| hyperthermia | 0.901227 |
| tissue characteristics | 0.386571 |
| hot water blankets | 0.375371 |
| peritoneal cavity | 0.431179 |
| hyperthermia techniques | 0.560349 |
| radiation therapy | 0.457463 |
|
| high temperatures | 0.42664 |
| primary peritoneal mesothelioma | 0.407141 |
| local hyperthermia | 0.597761 |
| body cavity | 0.386007 |
| cancer cells | 0.536875 |
| anticancer drugs | 0.424955 |
| Cancer Information Service | 0.393124 |
| Libutti SK | 0.372166 |
| tumor size | 0.36657 |
| certain anticancer drugs | 0.383187 |
| B.C. Decker Inc. | 0.373174 |
| Samulski TV. Hyperthermia | 0.573888 |
| Numerous clinical trials | 0.395138 |
| Clinical Trials Information | 0.383207 |
| malignant peritoneal mesothelioma | 0.399886 |
| body tissue | 0.392759 |
| Regional perfusion techniques | 0.40208 |
| Bast RC Jr. | 0.371129 |
| stomach cancer | 0.363295 |
| tumor | 0.394758 |
| inserts small needles | 0.373242 |
| et al | 0.437187 |
| higher temperatures | 0.384967 |
| research studies | 0.385011 |
|
CLICK HERE |
| 1768 |
National Cancer Institute |
Html |
es |
Perjuicios por fumar cigarrillos y beneficios para la salud al dejar el hábito |
Hoja informativa que contiene una lista de algunas de las sustancias del humo de tabaco que causan cáncer y describe los problemas de salud causados por fumar y los beneficios de dejar el hábito. |
| Neck Cancer Epidemiology | 0.422589 |
| Mortality Weekly Report | 0.414031 |
| Human Services | 0.435201 |
| An emerging health | 0.441866 |
| Annual smoking-attributable mortality | 0.414117 |
| National Health Interview | 0.418634 |
| productivity losses—united states | 0.413073 |
| muertes prematuras | 0.445781 |
| Disease Control | 0.419031 |
| tabaco sustancias | 0.451048 |
| emerging health crisis | 0.417693 |
| promoting smoking | 0.427125 |
| Health Benefits | 0.414213 |
| Estados Unidos | 0.436732 |
| Health Behavior | 0.414461 |
| olor. fumar kreteks | 0.444861 |
| smoking cessation after | 0.432247 |
| PubMed Abstract | 0.980608 |
| smoking cessation | 0.497845 |
| Smokeless Tobacco | 0.414167 |
| Second-hand Tobacco Smoke | 0.420375 |
| International Journal | 0.420012 |
| Smoking as | 0.425711 |
| Tobacco Research | 0.428882 |
| United States | 0.434188 |
|
| British Medical Journal | 0.433726 |
| early stage lung | 0.412709 |
| Causa cánceres | 0.417577 |
| causa enfermedades | 0.437169 |
| ambiente causa | 0.426356 |
| tobacco smoking | 0.490331 |
| obstructiva crónica | 0.447997 |
| tobacco aqueous pH | 0.419205 |
| Eissenberg T | 0.417223 |
| ambiente causa enfermedades | 0.423335 |
| causa inflamación | 0.413975 |
| Maziak W | 0.417052 |
| Ward KD | 0.4175 |
| systematic review | 0.417039 |
| muerte prematura | 0.420666 |
| Chronic Disease Prevention | 0.413895 |
| Andrology Prevention Weeks | 0.412666 |
| emerging health risk | 0.421288 |
| Cancer Institute | 0.452427 |
| leucemia mieloide aguda | 0.439669 |
| neck cancer | 0.417125 |
| cuánta nicotina | 0.415037 |
| Public Health Service | 0.416067 |
| New England Journal | 0.413417 |
|
CLICK HERE |
| 1833 |
National Cancer Institute |
Html |
es |
Tratamiento de los tumores carcinoides gastrointestinales (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento de los tumores carcinoides gastrointestinales. |
| metastatic carcinoid tumor | 0.417651 |
| carcinoides gi | 0.793345 |
| enfermedad cardÃaca carcinoide | 0.432281 |
| carcinoides duodenales | 0.478754 |
| células ec | 0.425941 |
| tracto gi | 0.460962 |
| Sin embargo | 0.46213 |
| tumores carcinoides gi | 0.491452 |
| PDQ Tumores neuroendocrinos | 0.416768 |
| imaging features with | 0.416291 |
| células neuroendocrinas gi | 0.414118 |
| marcadores carcinoides | 0.432817 |
| Exp Clin Cancer | 0.413418 |
| Cancer Res | 0.421273 |
| Res Clin Endocrinol | 0.414031 |
| Clin Gastroenterol | 0.414029 |
| sÃntomas carcinoides | 0.431545 |
| Pract Res Clin | 0.438075 |
| sÃndrome carcinoideo | 0.506176 |
| Clin Cancer Res | 0.414666 |
| patients with | 0.502884 |
| carcinoid tumors | 0.605663 |
| Best Pract Res | 0.431995 |
| Clin Endocrinol Metab | 0.422923 |
| carcinoid heart | 0.423722 |
|
| carcinoides celulares cse | 0.43559 |
| carcinoide celular cse | 0.415154 |
| tumores carcinoides | 0.966863 |
| neuroendocrine tumors | 0.59007 |
| TNE pancreáticos | 0.414445 |
| gastrointestinal tract | 0.419836 |
| tumores carcinoides gastrointestinales | 0.615452 |
| Surg Pathol | 0.422847 |
| Dig Dis Sci | 0.415197 |
| tumores tipo | 0.415164 |
| multiple endocrine neoplasia | 0.418143 |
| CSE tipo | 0.414261 |
| TNE GI | 0.460772 |
| tumores neuroendocrinos | 0.4479 |
| carcinoides esporádicos gi | 0.445952 |
| Surg Oncol | 0.418143 |
| with von recklinghausen | 0.424868 |
| somatostatin receptor | 0.413855 |
| neuroendocrine tumour | 0.454787 |
| tumores neuroendocrinos pancreáticos | 0.419002 |
| carcinoid tumor with | 0.413498 |
| Acad Sci | 0.415384 |
| gastrointestinal carcinoids | 0.415688 |
| tumores duodenales | 0.41576 |
|
CLICK HERE |
| 1949 |
National Cancer Institute |
Html |
es |
Tratamiento del linfoma relacionado con el sida (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del linfoma relacionado con el sida. |
| linfáticos afectados.ampliar linfoma | 0.30069 |
| estadio iiis+e | 0.227448 |
| células madre | 0.561403 |
| estadio iv | 0.248805 |
| siguientes elementos | 0.21398 |
| sudores nocturnos | 0.287643 |
| alto riesgo | 0.208757 |
| vÃa oral | 0.208173 |
| historial médico | 0.211748 |
| rayos x | 0.210669 |
| abdomen).ampliar linfoma | 0.262027 |
| estadio ie | 0.284505 |
| cáncer.ampliar aspiración | 0.213287 |
| lÃquido cefalorraquÃdeo | 0.384161 |
| punción espinal.Ampliar | 0.212727 |
| National Cancer Institute | 0.208952 |
| Instituto Nacional | 0.215593 |
| estadio iie | 0.283482 |
|
| PDQ Tratamiento | 0.219955 |
| segura medicamentos | 0.210953 |
| lÃquido incoloro | 0.216453 |
| siguientes biopsias | 0.213705 |
| estadio iiie | 0.319333 |
| siguientes problemas | 0.21343 |
| sistema nervioso central | 0.917575 |
| Physician Data Query | 0.232209 |
| cabo actividades | 0.210804 |
| ósea elabora glóbulos | 0.24265 |
| SNC).Ampliar Quimioterapia | 0.221029 |
| estadio iiis | 0.541053 |
| almacena células | 0.232785 |
| células b | 0.231648 |
| Estadio IIIE+S | 0.227106 |
| siguientes pruebas | 0.212565 |
| siguientes estadios | 0.212441 |
|
CLICK HERE |
| 1959 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de vagina (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de vagina. |
| parto).ampliar anatomÃa | 0.303951 |
| siguientes procedimientos | 0.324612 |
| siguientes aspectos | 0.303939 |
| pequeña cantidad | 0.302401 |
| estadio ii | 0.3299 |
| vÃa oral | 0.301938 |
| historial médico | 0.303531 |
| rayos x | 0.302933 |
| estadio ivb | 0.318379 |
| intensa luz | 0.302127 |
| Pap.Ampliar Prueba | 0.303248 |
| estadio iva | 0.313191 |
| National Cancer Institute | 0.301226 |
| realidad células | 0.307398 |
| vagina causa efectos | 0.315579 |
|
| sangrado anormal | 0.312233 |
| áreas anormales.ampliar examen | 0.305435 |
| Instituto Nacional | 0.302424 |
| PDQ Tratamiento | 0.308282 |
| presente sección | 0.301728 |
| Physician Data Query | 0.305028 |
| medicamento des | 0.324421 |
| prueba pap | 0.303798 |
| estadio iii | 0.307024 |
| pequeña incisión | 0.302169 |
| cuello uterino | 0.962189 |
| histerectomÃa abdominal | 0.303006 |
| procedimiento.ampliar ureteroscopÃa | 0.30314 |
| siguientes estadios | 0.303001 |
|
CLICK HERE |
| 2078 |
National Cancer Institute |
Html |
es |
Tomografía computarizada (TC) y exploraciones para cáncer |
Hoja informativa sobre el procedimiento y tecnología de la TC y sus usos para examen de detección, diagnóstico y tratamiento del cáncer. Hoja informativa 5.2s del Instituto Nacional del Cáncer. |
| imágenes llamada fdg | 0.212869 |
| hallazgos anómalos | 0.149049 |
| Pediatric Computed Tomography | 0.196499 |
| persona promedio | 0.156787 |
| Retrieved July | 0.224181 |
| rayos x | 0.774234 |
| from ct scans | 0.197405 |
| ACR Appropriateness Criteria® | 0.187415 |
| Patient Safety | 0.146744 |
| Low Levels | 0.215439 |
| Radiation Risks from | 0.30681 |
| radiation dose | 0.305638 |
| health care providers | 0.311726 |
| Lung Screening Trial | 0.175719 |
| risks from | 0.542401 |
| Assess Health Risks | 0.201898 |
| Retrieved June | 0.147049 |
| Exposición Innecesaria | 0.154118 |
| Internal Medicine | 0.215735 |
| Estados Unidos | 0.457591 |
| PubMed Abstract | 0.688591 |
| from ct | 0.241742 |
| mejores imágenes | 0.190153 |
| Cancer Imaging Program | 0.180886 |
| SEER Cancer Statistics | 0.179794 |
|
| Reducing Radiation from | 0.255009 |
| New Hampshire Avenue | 0.163654 |
| radiation risks | 0.481539 |
| alto riesgo | 0.166125 |
| Drug Administration | 0.216737 |
| British Medical Journal | 0.160951 |
| retrospective cohort study | 0.171194 |
| Mi Historia Médica | 0.162596 |
| lifetime attributable risk | 0.182458 |
| American College | 0.194044 |
| National Cancer Institute | 0.177442 |
| Health Risks from | 0.371263 |
| baja dosis | 0.918737 |
| dosis anual promedio | 0.421854 |
| from diagnostic imaging | 0.192917 |
| arteriopatÃa coronaria | 0.148972 |
| computed tomography | 0.455191 |
| Ionizing Radiation | 0.294632 |
| risks from exposure | 0.389205 |
| National Research Council | 0.163031 |
| pequeños riesgos | 0.152571 |
| Colegio Americano | 0.296344 |
| Estudio Nacional | 0.328775 |
| Sociedad Radiológica | 0.211562 |
|
CLICK HERE |
| 3551 |
National Cancer Institute |
Html |
en |
Cancer Statistics |
Basic information about cancer statistics in the U.S. and how they are used to understand the impact of cancer on society and to develop strategies that address the challenges that cancer poses. |
| cancer statistics | 0.699332 |
| major impact | 0.569457 |
| new screening test | 0.610486 |
| United States | 0.848591 |
| Asian/Pacific Islander women | 0.623563 |
| cancer death rate | 0.734611 |
| cancer deaths | 0.662668 |
| thyroid cancer | 0.618391 |
| SEER program website | 0.613262 |
| renal pelvis cancer | 0.675159 |
| population-based cancer registries | 0.661094 |
| African American men | 0.620993 |
| number | 0.579668 |
| new cancer cases | 0.74726 |
| American Cancer Society | 0.655347 |
| pancreatic cancer | 0.619919 |
| bladder cancer | 0.619451 |
| cancer-related deaths | 0.575865 |
| average age | 0.568157 |
| individual cancer types | 0.652597 |
| North American Association | 0.605716 |
| racial/ethnic group | 0.570832 |
| cancer care | 0.615369 |
| cancer diagnosis | 0.664799 |
|
| breast cancer | 0.617639 |
| rectum cancer | 0.622513 |
| large groups | 0.569141 |
| risk factor | 0.614571 |
| U.S. population | 0.610565 |
| people | 0.571698 |
| statistical trends | 0.613522 |
| age-adjusted mortality | 0.572947 |
| prostate cancer | 0.619132 |
| bronchus cancer | 0.62075 |
| Central Cancer Registries | 0.654709 |
| cancer survivors | 0.603772 |
| cancer mortality | 0.652323 |
| policy makers | 0.566593 |
| Understanding Cancer Prognosis | 0.676403 |
| endometrial cancer | 0.620993 |
| cancer | 0.951216 |
| new cases | 0.679157 |
| cancer incidence | 0.694185 |
| cancer death rates | 0.665983 |
| SEER Cancer Statistics | 0.665479 |
| overall cancer death | 0.735155 |
| cancer rates | 0.609223 |
|
CLICK HERE |